Pharmaceutical trends and the role of MES

Published: 26-Apr-2017
Media Manufacturing

With trends in the pharmaceutical industry continuously evolving, manufacturers are under increasing pressure to keep pace and adapt their operations to meet changing needs

You need to be a subscriber to read this article.
Click here to find out more.
Pharmaceutical trends and the role of MES

In this article, Christian Fortunel, Vice President of LZ Lifescience, discusses today’s most significant market trends, including continuous manufacturing, the increased demand for individualised medicines, patient-centricity and globalisation, as well as FDA’s focus on quality, and addresses the advantages that manufacturing execution systems (MES) bring in meeting the complexities of these developments.

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.

Subscribe now Already a subscriber? Sign in here.
See more

You may also like

Manufacturing
Your checkweigher is now a GMP data system — are you treating it like one?

Your checkweigher is now a GMP data system — are you treating it like one?

Read more
The weighing mechanism may be familiar. The regulatory expectations around the data it creates are becoming much harder to ignore.

Trending Articles

  1. Sterling Pharma Solutions doubles ADC manufacturing capacity at Deeside with new GMP suite The multi-million-pound expansion adds a 1400 sqft Grade C cleanroom, OEB5 containment handling and a 3400 sqft analytical laboratory — extending Sterling's bioconjugation capability from development through to Phase III and commercial scale
  2. Orano Med inaugurates Europe's first industrial-scale lead-212 radioligand therapy facility The €29m ATLab site will target up to 10,000 doses annually and its two-hour proximity to major European airports meets the critical 24-hour production-to-administration window imposed by lead-212's 10.6-hour half-life
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Why manufacturability needs a seat at the table earlier in drug development Chris Davison, CEO of Centrix Pharma, explains why considering manufacturability early in clinical development can reduce risk and support smoother progression to later-stage production
  4. Catalent launches ten-month gene-to-drug substance programme for complex biologics The accelerated pathway extends the CDMO's Rapid Antibody framework to bispecifics and next-generation formats — targeting master cell bank release by month seven and bulk drug substance lot release by month ten
  5. Hovione to install first ConsiGma CDC Flex continuous tableting line in US The CDMO is investing $35m in a next-generation continuous tableting line at its 89 Twin Rivers facility in New Jersey, creating an integrated US pathway from spray-dried amorphous solid dispersions to commercial tablet production

You may also like

Manufacturing
Your checkweigher is now a GMP data system — are you treating it like one?

Your checkweigher is now a GMP data system — are you treating it like one?

The weighing mechanism may be familiar. The regulatory expectations around the data it creates are becoming much harder to ignore.
Manufacturing
Step into cognitive manufacturing: Welcoming you to Booth S-1720

Step into cognitive manufacturing: Welcoming you to Booth S-1720

At Pack Expo 2026, IMA Group will showcase its latest innovations in processing, packaging, end-of-line, automation, as well as digital solutions and customer services across the Pharmaceutical, Med-Tech, Food, Personal Care, E-Commerce and Labeling industries
Media
Touchlight wins CPHI Pharma Award for cell-free DNA manufacturing

Touchlight wins CPHI Pharma Award for cell-free DNA manufacturing

The UK biotech's Doggybone DNA platform won the Innovation Catalyst category at CPHI Milan 2026, recognising its potential to support scalable DNA production for genetic medicines
Manufacturing
Xelia and Hisun sign strategic global multiple-API partnership

Xelia and Hisun sign strategic global multiple-API partnership

Long-standing joint venture partners expand collaboration, moving beyond anti-infective APIs into diversified therapeutic areas, including cardiovascular and oncology
Media
CPHI Pharma Awards 2026 recognise Touchlight, SeraNovo and Almac among fifteen category winners in Milan

CPHI Pharma Awards 2026 recognise Touchlight, SeraNovo and Almac among fifteen category winners in Milan

Touchlight's dbDNA platform took Innovation Catalyst, SeraNovo's NanoGlass oral formulation won Finished Formulation and Almac Clinical Services claimed Supply Chain Excellence — with BMS's Emma Charles named Woman of the Year
Manufacturing
Patented device reinvents Solid Phase Extraction

Patented device reinvents Solid Phase Extraction

Biotech Fluidics announce SPEedy - a device that provides an effortless way to perform Solid Phase Extraction (SPE) sample preparation procedures without need of an external vacuum and compatible with any adsorption chemistry or eluent composition
Media
CPHI Milan's inaugural Sustainability Summit brings 300+ companies together to tackle pharma's sustainability challenges

CPHI Milan's inaugural Sustainability Summit brings 300+ companies together to tackle pharma's sustainability challenges

The two-day programme addresses practical barriers to sustainable procurement, manufacturing and packaging — with hackathon-style sessions and cross-industry collaboration designed to move beyond targets into measurable operational action
Subscribe now